Status:
COMPLETED
Pharmacokinetic Evaluation of Testosterone Gel (1%)
Lead Sponsor:
Solvay Pharmaceuticals
Collaborating Sponsors:
Unimed Pharmaceuticals
Conditions:
Primary or Secondary Hypogonadism
Constitutional Delay in Growth and Puberty (CDGP)
Eligibility:
MALE
13-17 years
Phase:
PHASE1
Brief Summary
Measure and evaluate the level of testosterone in blood, and determine the safety and tolerability following daily applications of testosterone gel. Subjects who complete this trial may participate in...
Eligibility Criteria
Inclusion
- Diagnosis of primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP)
Exclusion
- Clinically significant uncontrolled medical condition or psychiatric disorder
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00193700
Start Date
August 1 2002
Last Update
December 25 2006
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 208
Birmingham, Alabama, United States
2
Site 203
Torrance, California, United States
3
Site 204
Jacksonville, Florida, United States
4
Site 201
Kansas City, Missouri, United States